Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin
Open Access
- 1 January 2018
- journal article
- review article
- Published by Medknow in Lung India
- Vol. 35 (2) , 143-149
Abstract
S in community and hospital settings. Management of community-acquired pneumonia (CAP) and AECB may pose challenges because of diagnostic difficulty in differentiating infections caused by typical and atypical microorganisms and rising rates of antimicrobial resistance. Beta-lactam antibiotics, macrolides, and fluoroquinolones are routinely prescribed medicines for the management of ALRTIs. Macrolides are time-tested and effective agents for the treatment of LRTIs. Clarithromycin, a macrolide, offers several benefits in the management of ALRTIs. In this article, we discuss the management approach of LRTIs with focus on clarithromycin in the management of mild-to-moderate LRTIs (CAP and AECB), i.e., in outpatient settings....Keywords
This publication has 47 references indexed in Scilit:
- Risk factors for community-acquired pneumonia in adults in Europe: a literature reviewThorax, 2013
- Etiology and outcome of severe community acquired pneumonia in immunocompetent adultsBMC Infectious Diseases, 2013
- Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide AntibioticsMediators of Inflammation, 2012
- Guidelines for diagnosis and management of community-and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendationsLung India, 2012
- Community-Acquired Pneumonia: An Unfinished BattleMedical Clinics of North America, 2011
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory MedicationsClinical Microbiology Reviews, 2010
- Mycoplasma pneumonia: Clinical features and managementLung India, 2010
- Bacteriological and clinical profile of Community acquired pneumonia in hospitalized patientsLung India, 2010
- Comparison of β-Lactam and Macrolide Combination Therapy versus Fluoroquinolone Monotherapy in Hospitalized Veterans Affairs Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2007
- Clarithromycin for Helicobacter pylori infectionExpert Opinion on Pharmacotherapy, 2000